Mauna Kea Technologies (Paris:MKEA) (NYSE Euronext: MKEA, FR0010609263) announced today that Joseph C. Liao MD, associate professor of urology, Stanford University, has successfully used endomicroscopy with Cellvizio for the first time in eight patients treated with robotic assisted radical prostatectomy (RARP) procedures. Results were presented in a poster presentation at the 2013 World Congress of […]
Mechelen (Belgium)/Lausanne (Switzerland) — Biocartis announced today the completion of an EUR 30 million Series E equity fundraising. The additional capital will be used to validate Biocartis’ molecular diagnostics platform IdyllaTM and its first assay and to continue the development of a range of assays, primarily in the oncology field. Biocartis is now in pole […]
Franklin Lakes, NJ and Paris, France – BD (Becton, Dickinson and Company), a leading global medical technology company, and FIND (Foundation for Innovative New Diagnostics) today announced a feasibility project that will evaluate the potential use of a low-cost, image-based TB screening platform that is currently in development. This platform provides ease-of-use and semi-quantitative automated […]
Franklin Lakes, NJ – BD Rx Inc., a wholly-owned subsidiary of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), announced today that the U.S. Food and Drug Administration (FDA) has approved Morphine Sulfate Injection, USP to be offered in the BD Simplist line of ready-to-administer prefilled injectables in the most common […]
Lexington, Mass. – Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that they will be attending Neuroscience 2013 on November 9 – 13, 2013 in San Diego, CA. Jeffrey Randall, Ph.D., Principal Scientist at Quanterix, will deliver a poster presentation on a […]
REDWOOD CITY, Calif. — Illumina, Inc. (NASDAQ:ILMN) today announced that the verifi® prenatal test,1 offered by Verinata Health, an Illumina company, will be available to pregnant women in California through the state’s Prenatal Screening Program. The availability of the verifi® prenatal test represents a major advance in prenatal screening, providing pregnant women with genetic information […]
OMAHA, Neb. — Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced that it has entered into a collaboration agreement with PerkinElmer, Inc.(NYSE: PKI) a global leader focused on improving the health and safety of […]
TORONTO — SQI Diagnostics Inc. (TSX-V: SQD), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics (“SQI”) today announced that they have entered into a method development agreement with Isis Pharmaceuticals (Isis) to develop a multiplexed assay that will utilize SQI’s Ig_PLEX™ multiplexing immunogenicity technology. “SQI […]
MEMPHIS, Tenn.—- Meridian Life Science, Inc., (MLS) of Memphis, Tennessee, a wholly-owned subsidiary ofMeridian Bioscience, Inc. (NASDAQ:VIVO), has been selected by the Centers for Disease Control and Prevention (CDC) to develop a process for manufacture of a rotavirus vaccine. Funding for this activity will be provided through a Small Business Innovation Research (SBIR) contract. Process […]
SAN JOSE, Calif. — Ariosa Diagnostics, Inc., won summary judgment yesterday in a patent infringement litigation involving U.S. Patent No. 6,258,540 against Sequenom, Inc., an exclusive licensee of the patent from Isis Innovations, Inc. The United States District Court for the Northern District of California invalidated the ‘540 patent at issue, giving Ariosa a complete […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
